Biochemical and biophysical research communicationsHumansAntineoplastic AgentsDNA-Binding ProteinsLipocalin-2Lung Neoplasms
Identification and validation of key covalent inhibitors targeting lung cancer proteins through integrated In Silico analysis.
Israr Fatima, Awaji Y Safhi, Abdullah Alsalhi, Ali Hanbashi, Abdulmajeed Jali, Hanan M Alsabei, Fahad M Alshabrmi, Fahad Y Sabei
Published: 202510.1016/j.bbrc.2025.152973
Abstract
Lung cancer remains the leading cause of cancer-related mortality worldwide, underscoring the urgent need for new and more effective therapeutics. In this study, an integrated in silico workflow was employed to identify and evaluate covalent inhibito…
Preview only. Read the full abstract at the source